Introduction {#Sec1}
============

Since the first report of pneumonia associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, Hubei Province, China in December 2019, the SARS-CoV-2 epidemic has become a major public health challenge in China and other countries (Huang *et al*. [@CR5]; Hui *et al*. [@CR6]; Lu *et al*. [@CR10]).

People of all ages are susceptible to SARS-CoV-2; however, current data have confirmed that adults, specifically older men with comorbidities, are more likely to be affected, suffering subsequently from severe pneumonia, pulmonary edema, acute respiratory distress syndrome, multiple organ failure, and death (Chen N *et al*. [@CR1]; Huang *et al*. [@CR5]; Wang *et al*. [@CR16]). Pregnancy is a special physiological condition with unique characteristics, including altered immunity and hormone levels which is required to tolerate and support the development and survival of the placenta and fetus in the hostile maternal immune system environment (Robinson and Klein [@CR12]). Compared with non-pregnant women, pregnant women are more severely affected by pathogenic infections, particularly those caused by respiratory pathogens, including the influenza and SARS viruses (Kourtis *et al*. [@CR8]; Sappenfield *et al*. [@CR13]; Wong *et al*. [@CR17]). A study had previously reported SARS-CoV-2 infection in nine pregnant women (Chen H *et al*. [@CR2]). However, the study primarily focused on the clinical characteristics and vertical transmission potential of SARS-CoV-2 infection in pregnant women. The changes in clinical features, laboratory characteristics, and imaging features of the pregnant women both before and after the delivery were not explored.

We retrospectively collected and analyzed detailed clinical data from eight pregnant patients, including six laboratory-confirmed SARS-CoV-2 infections and two highly suspected SARS-CoV-2 infection cases at the Maternal and Child Health Hospital of Hubei Province, Wuhan, China. The differences in clinical features, laboratory characteristics, and imaging features of pregnant women at pre-partum and post-partum were determined by examining the clinical features, laboratory characteristics, and imaging features of these patients.

Methods {#Sec2}
=======

Study Design and Patients {#Sec3}
-------------------------

We conducted a retrospective review of medical records of eight pregnant patients, including six laboratory-confirmed SARS-CoV-2 infections and two highly suspected SARS-CoV-2 infection cases, and five pregnant cases excluding SARS-CoV-2 infection admitted to the Maternal and Child Health Hospital of Hubei Province, Wuhan, China, from January 23 to February 10, 2020. The diagnosis was based on the World Health Organization interim guidance, and the New Coronavirus Pneumonia Prevention and Control Program published by the National Health Commission of China (National Health Commission of the PRC [@CR11]; WHO [@CR18]).

Data Collection {#Sec4}
---------------

The clinical records, laboratory findings, chest CT scans, and treatment and outcome data for all patients were reviewed and collected with data collection forms. Two study investigators independently reviewed the data collection forms to verify the data accuracy. The date of disease onset was defined as the day when the symptoms were identified.

Throat swab samples were collected and dispatched to the Hubei Provincial Center for Disease Control and Prevention for testing for SARS-CoV-2. A positive test result indicated a confirmed diagnosis of SARS-CoV-2 infection.

Results {#Sec5}
=======

The eight pregnant women were in their third trimester, six underwent cesarean section, and two underwent eutocia (Table [1](#Tab1){ref-type="table"}). Their ages ranged from 26 to 35 years, and the range of gestational weeks at admission was from 33 weeks (+ 6 days) to 40 weeks (+ 4 days).Table 1Baseline characteristics of 8 pregnant women infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).CharacteristicPatient 1Patient 2Patient 3Patient 4Patient 5Patient 6Patient 7Patient 8Age (years)2831303030262935Gestational age on admission39 weeks38 weeks, 1 day39 weeks, 1 day36 weeks, 4 days37 weeks, 6 days40 weeks, 3 days40 weeks, 4 days33 weeks, 6 daysOnset to delivery (days)Post-partum 1Post-partum 1NoNoNoNoPost-partum 2Pre-partum 1Fever on admissionNoNoNoNoNoNoNoYesPost-partum feverYesYesNoNoNoNoYesNoCoughNoNoNoNoNoNoNoNoOther symptomsNoNoNoNoNoNoNoNo*CT evidence of pneumonia*Pre-partum typical signs of viral infectionNoNoNoYesYesYesNoYesPost-partum typical signs of viral infectionNoNoYesYesYesYesYesYesSARS-CoV-2 RNAYesYesYesYesYesYesNANA*Delivery*Method of DeliveryC-sectionC-sectionC-sectionC-sectionVaginal deliveryC-sectionVaginal deliveryC-sectionIndication for C-sectionHistory of C-sectionPROMPre-eclampsiaPROMFetal distressHistory of C-section*Treatment*Intensive unit careNoNoNoNoNoNoNoNoMechanical ventilationNoNoNoNoNoNoNoNo*NA,* not available; *C*-*section;* cesarean section; *PROM,* premature rupture of membrane.

Seven of the eight patients had no fever, cough, or other symptoms before delivery. Three of the seven patients developed fever at the 1 or 2 days postpartum, and one demonstrated the typical ground-glass opacities in the lungs on chest CT scans as described previously (Huang *et al*. [@CR5]) (Table [1](#Tab1){ref-type="table"}; Fig. [1](#Fig1){ref-type="fig"}). The remaining four patients did not present with symptoms after delivery. Among which, three had typical ground-glass opacities in the lungs in chest CT scans before delivery and one developed ground-glass opacities in chest CT scans after delivery (Table [1](#Tab1){ref-type="table"}; Fig. [1](#Fig1){ref-type="fig"}). One of the eight patients had fever and typical ground-glass opacities on admission at 1-day pre-partum. None of the patients had a high fever (body temperature \> 39 °C) or developed a severe pneumonia, requiring intensive unit care or mechanical ventilation (Table [1](#Tab1){ref-type="table"}).Fig. 1Chest CT scans (transverse plane) of eight pregnant women with confirmed SARS-CoV-2 infection. Patients 1 and 2: no visible ground-glass opacities or small plaque; Patient 3--8: ground-glass opacities or/and small plaque are indicated by red arrow.

Laboratory test outcomes suggested that the white blood cell (WBC) counts of all eight patients were normal (patients 1--4 and 6--8) or slightly higher than the upper normal limit (patient 5) before delivery (Fig. [2](#Fig2){ref-type="fig"}A). However, the WBC counts of six patients drastically increased (patients 1--3, 5--6, and 8) after delivery, specifically for patients 1--2 and 5--6 (Fig. [2](#Fig2){ref-type="fig"}A). In contrast, a slight increase in WBC counts was observed in pregnant patients, excluding those with SARS-CoV-2 infection after delivery (Fig. [2](#Fig2){ref-type="fig"}B). The lymphocyte (LYMPH) counts were normal (patients 1--6 and 8) or slightly lower than the normal lower limit (patient 7) before delivery (Fig. [2](#Fig2){ref-type="fig"}A). However, the LYMPH counts of five patients drastically decreased (patients 1--3, 5--6) lower than the normal lower limit after delivery (Fig. [2](#Fig2){ref-type="fig"}A). In contrast, there were no obvious changes in the LYMPH counts of the pregnant patients without the SARS-CoV-2 infection between pre-partum and post-partum (Fig. [2](#Fig2){ref-type="fig"}B).Fig. 2Dynamic profile of white blood cells and lymphocyte count in pregnant women with or without severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Considering pregnant women with SARS-CoV-2 infection, patients 1--6 are pregnant patients with laboratory-confirmed SARS-CoV-2 infection, and patients 7--8 are pregnant patients with highly suspected SARS-CoV-2 infection. The left *y*-axis shows the number of white blood cells (WBC). The right *y*-axis shows the number of lymphocytes (LYMPH). The dotted lines in blue show the upper normal limit of the WBC count, and the dotted line in grey shows the lower normal limit of LYMPH count. *Pre,* pre-partum; *Post,* post-partum.

Furthermore, we closely monitored the C-reactive protein (CRP) levels, since it is an important marker and gauge of inflammation in the body (Wu *et al*. [@CR19]). Its levels were normal and comparable between pregnant women with SARS-CoV-2 infection and pregnant women without the SARS-CoV-2 infection before delivery (Fig. [3](#Fig3){ref-type="fig"}A). Patient CRP levels drastically increased postpartum. However, the mean serum CRP level was higher in patients with SARS-CoV-2 infection than in those without (Fig. [3](#Fig3){ref-type="fig"}A and Supplementary Table S1). D-dimer is one of the most important procoagulant markers, which may be elevated during viral infections (Subramaniam and Scharrer [@CR14]). The plasma D-dimer levels during the prepartum period were normal and comparable between pregnant women with SARS-CoV-2 infection and those without (Fig. [3](#Fig3){ref-type="fig"}B). However, D-dimer levels of four patients with SARS-CoV-2 infection increased significantly postpartum, but did not change in the five patients without SARS-CoV-2 infection (Fig. [3](#Fig3){ref-type="fig"}B and Supplementary Table S1). Both creatine kinase (CK) and creatine kinase-MB (CK-MB) levels increased in four pregnant women with SARS-CoV-2 infection after delivery (Fig. [3](#Fig3){ref-type="fig"}C, [3](#Fig3){ref-type="fig"}D and Supplementary Table S1). In terms of other laboratory tests, all eight patients with confirmed or highly suspected SARS-CoV-2 infection had normal levels of liver enzymes.Fig. 3The levels of inflammatory factors and kinase in pregnant women at pre-partum and post-partum. The pregnant women with SARS-CoV-2 infection included six pregnant patients with laboratory-confirmed SARS-CoV-2 infection and two pregnant patients with highly suspected SARS-CoV-2 infection. The participants without the SARS-CoV-2 infection. The levels of C-reactive protein (CRP), D-dimer, creatine kinase (CK), and creatine kinase-MB (CK-MB) in the serum or plasma were detected.

All patients received empirical antibiotic treatment and supportive care. None of the eight patients required intensive care or mechanical ventilation.

Discussion {#Sec6}
==========

This study reported new SARS-CoV-2 infected pregnant patients and revealed distant clinical presentations during the pre- and post-partum periods. Comprehensive data from clinical manifestations, laboratory examinations, and chest imaging were subsequently analyzed.

During pregnancy, several mechanical and pathophysiological adaptive changes occur in the respiratory system, including a decrease in respiratory volumes, increased oxygen consumption, and edema of the respiratory tract mucosa, which can render them intolerant to hypoxia. Moreover, immune adaptations are required to accommodate the fetus (Kourtis *et al*. [@CR8]). Therefore, pregnant women are particularly susceptible to respiratory pathogens and severe pneumonia. Previous studies have reported relatively more severe cases with higher mortality rates among pregnant women upon contracting respiratory viruses such as influenza virus and SARS virus (Gottfredsson [@CR4]; Jamieson *et al*. [@CR7]; Wong *et al*. [@CR17]). Pregnant SARS-CoV-2 patients reportedly presented with a similar pattern of clinical characteristics to that of non-pregnant adult patients (Chen H *et al*. [@CR2]; Huang *et al*. [@CR5]). An investigation in 138 hospitalized patients with COVID showed that 98.6% patients had clinical manifestations of fever, 69.6% patients had fatigue, and 59.4% patients had dry cough. In addition, 70.3% patients had lymphopenia and 39.9% had elevated lactate dehydrogenase. Chest computed tomographic (CT) scans showed that all patients presented bilateral patchy shadows or ground glass opacity in the lungs of all patients (Wang *et al*. [@CR16]). Another descriptive study in 99 cases with COVID reported that 83% patients had fever, 82% patients had cough, and 31% patients had shortness of breath. Other clinical manifestations include muscle ache, confusion, headache, sore throat and so on. The imaging examination showed that 75% patients presented bilateral pneumonia, 14% patients showed multiple mottling and ground-glass opacity (Chen N *et al*. [@CR1]). Here, four patients had no symptoms during the observation period; additionally, the only symptom observed in the remaining patients was fever. The liver enzyme levels in all eight patients were also normal. As far as the imaging features were concerned, the typical signs of viral infection-ground-glass opacity in the lungs were also mild. Therefore, according to our study, SARS-CoV-2 infected pregnant patients appeared to present with relatively milder clinical symptoms than non-pregnant adult patients.

Our study revealed that four of the eight pregnant women were asymptomatic before delivery but became symptomatic after delivery. Correspondingly, WBC counts increased while LYMPH counts decreased in most pregnant patients with SARS-CoV-2 infection. Furthermore, CRP levels increased considerably higher than those observed during general pregnancy. During pregnancy, the concentrations of steroid hormones such as estrogens and progesterone progressively increase over the course of pregnancy (Vojtek *et al*. [@CR15]). In addition, to ensure that the mother's body can actively tolerate the semi-allogeneic fetus, the immune system is modulated (Vojtek *et al*. [@CR15]). However, there is a sudden and substantial decrease in steroid hormone concentrations during the immediate postpartum period (Dennis *et al*. [@CR3]). In comparison to the third trimester of pregnancy, there is a significant change in immune cells including the blood phagocytes, pDCs, NK cells, and T cells during the post-partum period (Kraus *et al*. [@CR9]). It is possible that these alterations in both the hormones and immune system trigger the onset of SARS-CoV-2 infection following partum. Further investigations are needed to elucidate the immunological differences between pre- and post-partum in the context of combating a SARS-CoV-2 infection.

Summarily, our results suggest that compared to non-pregnant adult patients, pneumonia and other symptoms were mild in pregnant patients with SARS-CoV-2 infection. A number of pregnant women presented with asymptomatic SARS-CoV-2 infection pre-partum, but the disease onset may occur post-partum. Close monitoring of laboratory parameters such as WBC count, LYMPH count, and CRP as well as the imaging features in chest CT scans, may be helpful for the early prevention, diagnosis, and treatment of SARS-CoV-2 infection during pregnancy.
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